Abstract
Bacterial lipopolysaccharide (LPS) is present in the outer membrane of Gram-negative bacteria and functions as pathogen-associated molecular pattern (PAMP) (Whitfield and Trent, 2014). LPS therefore is a potent activator of inflammatory responses leading to cytokine release and neutrophils recruitment. The lipid A moiety of LPS activates the complex consisting of the LPS binding protein (LBP), CD14, MD-2 and Toll-like receptor 4 (TLR4) and the non-canonical inflammasome-linked caspases-4, 5 and 11, which in turn activate the canonical NLRP3 inflammasome (Shi et al., 2014; Hagar et al., 2013; Kayagaki et al., 2013; Hoshino et al., 1999; Poltorak, 1998; Nagai et al., 2002; Park et al., 2009; Ratsimandresy et al., 2013). In particular, the cytokine interleukin (IL)-1β produced in response to inflammasome activation has a crucial role in neutrophil recruitment through promoting neutrophil adhesion and migration (McDonald et al., 2010).This protocol allows studying of inflammatory response induced by LPS that affect neutrophil infiltration by tracking myeloperoxidase (MPO) activity in vivo (de Almeida et al., 2015).
Materials and Reagents
Insulin syringes (Thermo Fisher Scientific, catalog number: 14-841-31)
0.22 μm filters
C57BL/6 mice, typically of 8-12 weeks old mice (male or female)
LPS E.coli 0111:B4 (Sigma-Aldrich, catalog number: L2630-100MG)
Dulbecco's phosphate-buffered saline (DPBS) (Corning, catalog number: 21-030-CV)
XenoLight RediJect inflammation probe (PerkinElmer, catalog number: 760535)
Luminol sodium salt (Sigma-Aldrich, catalog number: A4685)
Isofluorane (Henry Schein, Isothesia&trade, catalog number: 10014450)
5 mg/ml LPS (see Recipes)
20 mg/ml luminol sodium salt stock solution (see Recipes)
Equipment
Anesthesia machine (VetEquip, model: 901808) or similar anesthesia equipment
Rechargeable trimmer (Braintree Scientific, catalog number: VLP-323 75)
Scale (Kent Scientific, catalog number: SCL66110)
Biosafety cabinet
IVIS spectrum (PerkinElmer, model: 124262) or a comparable luminescence imaging equipment
Software
Living Image software (PerkinElmer)
Procedure
Two days before the LPS intra peritoneal injection place mice in the anesthesia machine and once the mice are anesthetized shave abdominal area with a trimmer, as fur quenches the luminescence signal (Figure 1).
Weigh mice.
In the day of the experiment dilute LPS in DPBS and prepare syringes for injection.
Intraperitoneally inject mice with 2.5 mg/kg of LPS or the same volume DPBS for the control group (injection volume approximately 200 μl).
3 h later intraperitoneally inject mice with 200 mg/kg of XenoLight Rediject inflammation probe or 200 mg/kg luminol sodium salt (injection volume approximately 200 μl).
Place mice in the IMPAC6 anesthesia chamber attached to the IVIS spectrum.
Transfer mice to the IVIS spectrum and place mice abdomen facing up into the chamber and position each nose inside the cone that delivers the isofluorane (Figure 2).
Start imaging anesthetized mice 10 min post XenoLight Rediject inflammation probe injection with a 5 min exposure capturing in vivo bioluminescence generated by the activity of MPO as a marker for infiltration of neutrophils. In order to imagine 5 mice select field of view D and select 1.5 cm subject height (Figures 2 and 3) (Gross et al., 2009; Tseng and Kung, 2012).
Quantify the MPO signal using the Living Image software. First select region of interest (ROI) using ROI tools and choose to automatically draw measurement ROIs and perform ROI analyses to measure photon radiance. Also measure background ROI and subtract from your ROI measurement. Use average radiance to plot your graph.
Figure 1. A representative picture of mice under anesthesia getting their abdominal area shaved with a trimmer.

Figure 2. A representative example of in vivo imaging in 8 wk of age male C57BL/6 mice after i.p. injection of PBS (left) or LPS (2.5 mg/kg body weight) (right).

Figure 3. Screen capture image of the IVIS acquisition control panel.

Recipes
-
5 mg/ml LPS
Dilute LPS in DPBS.
Filter sterilize with a 0.22 μm filter and aliquot stock solution at -80 °C.
-
20 mg/ml luminol sodium salt stock solution
Prepare 20 mg/ml luminol sodium salt stock solution in DPBS.
Note: Luminol sodium salt for injection has to be prepared fresh each time in DPBS (20 mg/ml), filter sterilize with a 0.22 μm filter and protected from light until use.
Acknowledgments
This protocol was adapted from a previously published study (de Almeida et al., 2015). This work was supported by grants from the National Institutes of Health (AI099009 and AR064349 to C.S., AR066739 to A.D., AI120625 and AI120618 to C.S. and A.D., T32AR007611 to L.d.A., and the American Heart Association 13GRNT17110117 to C.S.).
References
- de Almeida L, Khare S, Misharin AV, Patel R, Ratsimandresy RA, Wallin MC, Perlman H, Greaves DR, Hoffman HM, Dorfleutner A, Stehlik C. The PYRIN domain-only protein POP1 inhibits inflammasome assembly and ameliorates inflammatory disease. Immunity. 2015;43(2):264–276. doi: 10.1016/j.immuni.2015.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross S, Gammon ST, Moss BL, Rauch D, Harding J, Heinecke JW, Ratner L, Piwnica-Worms D. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat Med. 2009;15(4):455–461. doi: 10.1038/nm.1886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS activates caspase-11 : implications in TLR4-independent endotoxic shock. Science. 2013;341(6151):1250–1253. doi: 10.1126/science.1240988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999;162(7):3749–3752. [PubMed] [Google Scholar]
- Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszynski A, Forsberg LS, Carlson RW, Dixit VM. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 2013;341(6151):1246–1249. doi: 10.1126/science.1240248. [DOI] [PubMed] [Google Scholar]
- McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 2010;330(6002):362–366. doi: 10.1126/science.1195491. [DOI] [PubMed] [Google Scholar]
- Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol. 2002;3(7):667–672. doi: 10.1038/ni809. [DOI] [PubMed] [Google Scholar]
- Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009;458(7242):1191–1195. doi: 10.1038/nature07830. [DOI] [PubMed] [Google Scholar]
- Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282(5396):2085–2088. doi: 10.1126/science.282.5396.2085. [DOI] [PubMed] [Google Scholar]
- Ratsimandresy RA, Dorfleutner A, Stehlik C. An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology. Front Immunol. 2013;4:440. doi: 10.3389/fimmu.2013.00440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187–192. doi: 10.1038/nature13683. [DOI] [PubMed] [Google Scholar]
- Tseng JC, Kung AL. In vivo imaging of inflammatory phagocytes. Chem Biol. 2012;19(9):1199–1209. doi: 10.1016/j.chembiol.2012.08.007. [DOI] [PubMed] [Google Scholar]
- Whitfield C, Trent MS. Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem. 2014;83:99–128. doi: 10.1146/annurev-biochem-060713-035600. [DOI] [PubMed] [Google Scholar]
